Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562Kylie M Drake, E Cristy Ruteshouser, Rachael Natrajan, et al.The Journal of Pathology|March 1, 2012
Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group studySamantha Gadd, Patricia Beezhold, Lawrence Jennings, et al.Neoplasia (New York, N.Y.)|September 7, 2012
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group StudySamantha Gadd, Vicki Huff, Chiang-Ching Huang, et al.The Journal of Clinical Investigation|October 26, 2010
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human modelsSilvestre Vicent, Ron Chen, Leanne C Sayles, et al.Journal of the American College of Surgeons|March 25, 2014
Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimensJaime M Libes, Erin H Seeley, Ming Li, et al.Cell Reports. Medicine|May 26, 2022
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 studySamantha Gadd, Vicki Huff, Andrew D Skol, et al.Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.Nature Communications|August 23, 2019
Wilm's tumor 1 promotes memory flexibilityChiara Mariottini, Leonardo Munari, Ellen Gunzel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study GroupPaul E Grundy, Norman E Breslow, Sierra Li, et al.Research Square|July 1, 2024
The UTHealth Houston Adult Cardiovascular Genomics Certificate Program: Efficacy and Impact on Healthcare ProfessionalsMelyssa Garner, Bansari Rajani, Priyanka Vaidya, et al.Pageof 6